Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FK39E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,007
Award facts
- Contract value 100% obligated
- $29,007.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,007.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of September 9, 2025. This non-set-aside contract was awarded competitively on September 8, 2025, with performance to be completed at the company's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as the prime contractor on this delivery order, which falls under a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.99 million through December 2026.
The delivery order supports the Defense Logistics Agency's Medical Supply Chain operations by procuring Dupixent, a biologic immunosuppressant medication used primarily for treating moderate-to-severe eczema, asthma, and other inflammatory conditions. As a child contract under the broader DLA pharmaceutical prime vendor arrangement, this order exemplifies the agency's ongoing strategy to maintain reliable supply chains for specialty pharmaceuticals needed across military healthcare programs and the Defense Health Agency. AmerisourceBergen's demonstrated capability in fulfilling diverse pharmaceutical delivery orders through competitive federal procurement, combined with its comprehensive IDC vehicle, positions it as a key supplier for the department's medical readiness requirements.
Quick answers
Who was awarded contract SPE2DB25FK39E?
SPE2DB25FK39E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FK39E worth?
The government has obligated $29,007 on SPE2DB25FK39E.
Is contract SPE2DB25FK39E an order under another contract?
Yes. SPE2DB25FK39E is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK39E competed?
The extent of competition for SPE2DB25FK39E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award